Increased Hospitalizations Involving Fungal Infections during COVID-19 Pandemic, United States, January 2020-December 2021

Increased Hospitalizations Involving Fungal Infections during COVID-19 Pandemic, United States, January 2020-December 2021

Hospitalizations involving fungal infections increased 8.5% each year in the United States during 2019-2021. During 2020-2021, patients hospitalized with COVID-19-associated fungal infections had higher (48.5%) in-hospital mortality rates than those with non-COVID-19-associated fungal infections (12...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Emerging infectious diseases 2023-07, Vol.29 (7), p.1433-1437
Hauptverfasser: Gold, Jeremy A W, Adjei, Stacey, Gundlapalli, Adi V, Huang, Ya-Lin A, Chiller, Tom, Benedict, Kaitlin, Toda, Mitsuru
Format: Artikel
Sprache:eng
Schlagworte:
Actinomycosis
Antifungal agents
Aspergillosis
Blastomycosis
candidiasis
Coccidioidomycosis
COVID-19
COVID-19 - epidemiology
Cryptococcosis
Disease control
Disease prevention
Dispatch
Epidemics
Epidemiology
Fungal infections
Fungi
Health aspects
Health care
Health services utilization
Health surveillance
Histoplasmosis
Hospital care
Hospitalization
hospitalizations
Hospitals
Humans
Illnesses
Infection
Infectious diseases
invasive fungal infections
Medical care, Cost of
Molds (Fungi)
Mortality
Mucormycosis
Mycoses
Mycoses - epidemiology
Nocardia Infections
Pandemics
Patient outcomes
Patients
Public health
Risk factors
Severe acute respiratory syndrome coronavirus 2
Statistics
Steroids
Trends
United States - epidemiology
Vital statistics
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Hospitalizations involving fungal infections increased 8.5% each year in the United States during 2019-2021. During 2020-2021, patients hospitalized with COVID-19-associated fungal infections had higher (48.5%) in-hospital mortality rates than those with non-COVID-19-associated fungal infections (12.3%). Improved fungal disease surveillance is needed, particularly during respiratory virus pandemics.
ISSN:1080-6040
1080-6059
DOI:10.3201/eid2907.221771